Related Experiment Videos
Detection of nevirapine in plasma using thin-layer chromatography
Jeffrey G Dubuisson1, Jennifer R King, Jeffrey S A Stringer
1Division of Clinical Pharmacology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham School of Medicine, USA.
Journal of Acquired Immune Deficiency Syndromes (1999)
|January 15, 2004
Summary
A new thin-layer chromatography (TLC) method quickly and affordably detects Nevirapine (NVP) in plasma. This aids in monitoring HIV treatment adherence for pregnant women in resource-limited settings.
Area of Science:
- Pharmacology
- Analytical Chemistry
- Public Health
Background:
- Nevirapine (NVP) is crucial for preventing mother-to-child HIV transmission in resource-poor settings.
- Accurate adherence monitoring is challenging due to misreporting, necessitating alternative detection methods.
- Existing drug quantification techniques can be expensive and time-consuming.
Purpose of the Study:
- To develop and validate a rapid, inexpensive method for detecting Nevirapine (NVP) in human plasma.
- To provide a practical tool for assessing drug exposure in clinical settings.
- To improve HIV management strategies in resource-limited environments.
Main Methods:
- Thin-layer chromatography (TLC) was employed for NVP detection.
- Solid-phase extraction was used to isolate NVP from spiked plasma samples.
- The TLC method was validated using clinical samples with known NVP concentrations.
Main Results:
- NVP was detectable at concentrations as low as 60 ng/mL.
- A lower limit of detection of 100 ng/mL was established for clear visualization.
- The TLC assay provides results within hours at a significantly lower cost than standard methods.
Conclusions:
- TLC offers a sensitive, rapid, and economical qualitative method for measuring NVP in plasma.
- This technique can serve as a valuable tool for clinicians to monitor adherence in resource-poor regions.
- Improved adherence monitoring can enhance the effectiveness of HIV prevention programs, particularly for pregnant women.